Career Development Program

职业发展计划

基本信息

批准号：
7715196
负责人：
CLARA D BLOOMFIELD
金额：
$ 14.97万
依托单位：
OHIO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-07-01 至 2014-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7715196
关键词：
Academia Academic Medical Centers Advisory Committees Animal Model Area Award Basic Science Bioinformatics Biological Markers Cancer and Leukemia Group B Clinic Clinical Clinical Oncology Supplement (K12)Clinical Research Clinical Sciences Clinical Trials Clinical and Translational Science Awards Commit Comprehensive Cancer Center Consultations Dental Students Diagnosis Disease Doctor of Philosophy Education Educational process of instructing Eligibility Determination Engineering Enrollment Epidemiology Etiology Evaluation Experimental Leukemia Faculty Fellowship Funding Future Gender Genetic Programming Goals Grant Health Hematology Human Human Resources Individual Institutional National Research Service Award Internal Medicine Laboratories Laboratory Scientists Link Medical Medicine Mentors Mentorship Minority Modeling Mus Nurses Ohio Patient Care Patients Peer Review Pharmacology Pharmacy facility Phase Physicians Population Positioning Attribute Prevention Public Health Qualifying Recommendation Recruitment Activity Reproduction spores Research Research Personnel Research Training Resources SECTM1 gene Science Scientist Stereotyping Subgroup Therapeutic Time Training Training Programs Training Support Training and Education Translational Research United States National Institutes of Health Universities Veterinary Medicine Waiting Lists Woman Women Physicians Work base cancer genetics career career development college design drug development experience human disease interest leukemia member novel diagnostics novel strategies novel therapeutics oncology population based post-doctoral training pre-clinical pre-doctoral professor programs response success therapeutic development tumor immunology

项目摘要

The Career Development Program (CDP) is an important component of this Leukemia SPORE application and the national SPORE program because it will assure a cadre of academic faculty who are translational scientists dedicated to discover and apply new approaches to understanding the etiology and epidemiology, prevention, diagnosis, treatment and cure of patients with leukemia. The goal of our CDP is to recruit, provide training and guidance {i.e. mentor and develop) and retain academic faculty level physicianscientists, clinician-investigators, and laboratory-based scientists who will dedicate their endeavors to leukemia translational research. Our focus will be primarily on recruitment of assistant professors. We will place special emphasis on recruiting qualified women and minorities. Indeed, all three of the candidates chosen for the first year positions are women and one is a minority. While any area of translational leukemia research will be considered, we will place special emphasis in our areas of strength which include human cancer genetics, animal models and preclinical and clinical experimental therapeutics. The goal will be to fund three positions at $100,000 each for one to three years. Applications will be solicited from all departments and centers at the Ohio State University Comprehensive Cancer Center (OSUCCC) and by the SPORE Administrative Core. They will be screened for eligibility and diversity by the CDP Leader before formal review begins to assure that the pool contains qualified women and minorities. Applications will be judged based on the potential of the candidate, the strength of the proposed research and the appropriateness of the mentors. Applications will be formally reviewed, scored and ranked by members of the SPORE CDP Steering Committee. Final selection will be made by the CDP Leader and SPORE Program Director in consultation with the SPORE Executive Committee. Each position will be funded for one year, with eligibility for a second and third year dependent upon satisfactory annual progress following evaluation by the awardee's co-mentors and the SPORE Executive Committee. The SPORE will provide $150,000 annual funding to the program; $150,000 annually in matching funds will be provided from the OSUCCC. Success of the program will be judged by the quality, of the science generated by the awardees, their success in obtaining external peer reviewed funding, their success in academic advancement and their retention in academia and leukemia translational research.

职业发展计划（CDP）是该白血病孢子应用的重要组成部分以及国家孢子计划，因为它将确保翻译的学术教师的干部科学家致力于发现并采用新方法来理解病因和流行病学，白血病患者的预防，诊断，治疗和治疗。我们CDP的目标是招募提供培训和指导{即指导和发展）并保留学术教师医师科学家，临床医生评估者和基于实验室的科学家，他们将努力白血病转化研究。我们的重点将主要是招募助理教授。我们将特别强调招募合格的妇女和少数民族。确实，这三个候选人在第一年的职位上选择的是女性，一个是少数。而转化白血病的任何领域将考虑研究，我们将特别重点在我们的力量领域，包括人类癌症遗传学，动物模型以及临床前和临床实验疗法。目标是在一到三年内以每100,000美元的价格资助三个职位。申请将是来自俄亥俄州立大学综合癌症中心的所有部门和中心（OSUCCC）和孢子管理核心。他们将被筛选以获得资格和多样性在正式审查之前，CDP负责人开始确保池包含合格的妇女和少数民族。将根据候选人的潜力来判断申请，拟议研究的优势以及导师的适当性。申请将被正式审查，评分和排名孢子CDP指导委员会的成员。最终选择将由CDP负责人和孢子计划主任与孢子执行委员会协商。每个位置将是资助一年，有资格获得第二年和第三年，取决于令人满意的年度进度经过获奖者的联合会和孢子执行委员会的评估。孢子会向该计划提供15万美元的年度资金；每年将提供$ 150,000的匹配资金 OSUCCC。该计划的成功将由质量，科学的质量来判断获奖者，他们在获得外部同行评审资金方面的成功，他们在学术方面的成功进步及其在学术界和白血病转化研究中的保留。